He et al. 38 indicated that miR-26 induced apoptosis and restrained autophagy based on the TGF-β1-JNK signaling pathway, recommending that miR-26 could be a useful novel target for the treatment of non-small cell lung cancer (NSCLC). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.